146 related articles for article (PubMed ID: 35116323)
1. Exploring the molecular targets and mechanisms of [10]-Gingerol for treating triple-negative breast cancer using bioinformatics approaches, molecular docking, and
Huang P; Zhou P; Liang Y; Wu J; Wu G; Xu R; Dai Y; Guo Q; Lu H; Chen Q
Transl Cancer Res; 2021 Nov; 10(11):4680-4693. PubMed ID: 35116323
[TBL] [Abstract][Full Text] [Related]
2. Exploring the mechanism of an active ingredient of ginger, dihydrocapsaicin, on triple negative breast cancer based on network pharmacology and
Luo L; Chen Y; Ma Q; Huang Y; Hong T; Shu K; Liu Z
Oncol Lett; 2023 May; 25(5):195. PubMed ID: 37113393
[TBL] [Abstract][Full Text] [Related]
3. 10-Gingerol Enhances the Effect of Taxol in Triple-Negative Breast Cancer via Targeting ADRB2 Signaling.
Liang Y; Wu G; Luo T; Xie H; Zuo Q; Huang P; Li H; Chen L; Lu H; Chen Q
Drug Des Devel Ther; 2023; 17():129-142. PubMed ID: 36712945
[TBL] [Abstract][Full Text] [Related]
4. [10]-Gingerol Affects Multiple Metastatic Processes and Induces Apoptosis in MDAMB- 231 Breast Tumor Cells.
Fuzer AM; Martin ACBM; Becceneri AB; da Silva JA; Vieira PC; Cominetti MR
Anticancer Agents Med Chem; 2019; 19(5):645-654. PubMed ID: 30370858
[TBL] [Abstract][Full Text] [Related]
5. Screening of Active Substances Regulating Alzheimer's Disease in Ginger and Visualization of the Effectiveness on 6-Gingerol Pathway Targets.
Pan Y; Li Z; Zhao X; Du Y; Zhang L; Lu Y; Yang L; Cao Y; Qiu J; Qian Y
Foods; 2024 Feb; 13(4):. PubMed ID: 38397589
[TBL] [Abstract][Full Text] [Related]
6. Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation.
Zhang Z; Liu J; Liu Y; Shi D; He Y; Zhao P
J Ethnopharmacol; 2021 Apr; 269():113696. PubMed ID: 33358854
[TBL] [Abstract][Full Text] [Related]
7. [10]-gingerol induces apoptosis and inhibits metastatic dissemination of triple negative breast cancer
Martin ACBM; Fuzer AM; Becceneri AB; da Silva JA; Tomasin R; Denoyer D; Kim SH; McIntyre KA; Pearson HB; Yeo B; Nagpal A; Ling X; Selistre-de-Araújo HS; Vieira PC; Cominetti MR; Pouliot N
Oncotarget; 2017 Sep; 8(42):72260-72271. PubMed ID: 29069785
[TBL] [Abstract][Full Text] [Related]
8. Mechanism exploration of 6-Gingerol in the treatment of atherosclerosis based on network pharmacology, molecular docking and experimental validation.
Hu Y; Liu T; Zheng G; Zhou L; Ma K; Xiong X; Zheng C; Li J; Zhu Y; Bian W; Zheng X; Xiong Q; Lin J
Phytomedicine; 2023 Jul; 115():154835. PubMed ID: 37121058
[TBL] [Abstract][Full Text] [Related]
9. Autophagy-dependent apoptosis is triggered by a semi-synthetic [6]-gingerol analogue in triple negative breast cancer cells.
Luna-Dulcey L; Tomasin R; Naves MA; da Silva JA; Cominetti MR
Oncotarget; 2018 Jul; 9(56):30787-30804. PubMed ID: 30112107
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological network study on the effect of 6-gingerol on cervical cancer using computerized databases.
Martínez-Esquivias F; Guzmán-Flores JM; Chávez-Díaz IF; Iñiguez-Muñoz LE; Reyes-Chaparro A
J Biomol Struct Dyn; 2023 Sep; ():1-12. PubMed ID: 37776009
[TBL] [Abstract][Full Text] [Related]
11. The Role and Mechanism of CRT0066101 as an Effective Drug for Treatment of Triple-Negative Breast Cancer.
Liu Y; Wang Y; Yu S; Zhou Y; Ma X; Su Q; An L; Wang F; Shi A; Zhang J; Chen L
Cell Physiol Biochem; 2019; 52(3):382-396. PubMed ID: 30845378
[TBL] [Abstract][Full Text] [Related]
12. The Modulatory Properties of
Liu C; Wang K; Zhuang J; Gao C; Li H; Liu L; Feng F; Zhou C; Yao K; Deng L; Wang L; Li J; Sun C
Front Pharmacol; 2019; 10():1171. PubMed ID: 31680955
[No Abstract] [Full Text] [Related]
13. [10]-Gingerol-Loaded Nanoemulsion and its Biological Effects on Triple-Negative Breast Cancer Cells.
Zanesco-Fontes I; Silva ACL; da Silva PB; Duarte JL; Di Filippo LD; Chorilli M; Cominetti MR; Martin ACBM
AAPS PharmSciTech; 2021 May; 22(5):157. PubMed ID: 34008089
[TBL] [Abstract][Full Text] [Related]
14. Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification.
Zhang Y; Ma X; Li H; Zhuang J; Feng F; Liu L; Liu C; Sun C
Front Pharmacol; 2021; 12():685773. PubMed ID: 34858165
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics and experimental studies of anti-leukemic activity from 6-gingerol demonstrate its role in p53 mediated apoptosis pathway.
Chatupheeraphat C; Nantasenamat C; Deesrisak K; Roytrakul S; Anurathapan U; Tanyong D
EXCLI J; 2020; 19():582-595. PubMed ID: 32483405
[TBL] [Abstract][Full Text] [Related]
16. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers.
Liu Y; Teng L; Fu S; Wang G; Li Z; Ding C; Wang H; Bi L
BMC Cancer; 2021 May; 21(1):644. PubMed ID: 34053447
[TBL] [Abstract][Full Text] [Related]
17. Network Pharmacology-Based Identification of Key Mechanisms of Xihuang Pill in the Treatment of Triple-Negative Breast Cancer Stem Cells.
Zhang YZ; Yang JY; Wu RX; Fang C; Lu H; Li HC; Li DM; Zuo HL; Ren LP; Liu XY; Xu R; Wen JH; Huang HD; Hong R; Chen QJ
Front Pharmacol; 2021; 12():714628. PubMed ID: 34737698
[TBL] [Abstract][Full Text] [Related]
18. Systems pharmacology in combination with proteomics reveals underlying mechanisms of Xihuang pill against triple-negative breast cancer.
Xu X; Zhang J; Zhang Z; Wang M; Liu Y; Li X
Bioengineered; 2020 Dec; 11(1):1170-1188. PubMed ID: 33092442
[TBL] [Abstract][Full Text] [Related]
19. Coordinated regulation of WNT/β-catenin, c-Met, and integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits.
Giacomelli C; Jung J; Wachter A; Ibing S; Will R; Uhlmann S; Mannsperger H; Sahin Ö; Yarden Y; Beißbarth T; Korf U; Körner C; Wiemann S
BMC Cancer; 2021 Dec; 21(1):1296. PubMed ID: 34863149
[TBL] [Abstract][Full Text] [Related]
20. [10]-Gingerol improves doxorubicin anticancer activity and decreases its side effects in triple negative breast cancer models.
Baptista Moreno Martin AC; Tomasin R; Luna-Dulcey L; Graminha AE; Araújo Naves M; Teles RHG; da Silva VD; da Silva JA; Vieira PC; Annabi B; Cominetti MR
Cell Oncol (Dordr); 2020 Oct; 43(5):915-929. PubMed ID: 32761561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
